Article Details

Merck expands cancer immunotherapy pipeline with $680m Harpoon acquisition - PMLiVE

Retrieved on: 2024-01-11 18:17:38

Tags for this article:

Click the tags to see associated articles and topics

Merck expands cancer immunotherapy pipeline with $680m Harpoon acquisition - PMLiVE. View article details on hiswai:

Excerpt

... monoclonal antibody, which could allow for faster diffusion into solid tumour tissue. The company's pipeline includes HPN328, a T-cell engager ...

Article found on: www.pmlive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up